Key Quantitative Figures - Consolidated Results

Quarterly Performance (Q2 FY26-27 vs Q2 FY25-26):

  • Revenue from operations: ₹795.21 million (₹722.65 million in Q2 FY25)
  • Total income: ₹816.90 million (₹746.52 million in Q2 FY25)
  • Profit before tax: ₹117.35 million (₹94.22 million in Q2 FY25)
  • Profit after tax: ₹100.36 million (₹85.32 million in Q2 FY25)
  • Basic EPS: ₹1.82 (₹1.59 in Q2 FY25)

Half-Yearly Performance (H1 FY26-27 vs H1 FY25-26):

  • Revenue from operations: ₹1,542.17 million (₹1,378.62 million in H1 FY25)
  • Total income: ₹1,586.84 million (₹1,419.71 million in H1 FY25)
  • Profit before tax: ₹237.76 million (₹190.17 million in H1 FY25)
  • Profit after tax: ₹203.51 million (₹168.62 million in H1 FY25)
  • Basic EPS: ₹3.70 (₹3.10 in H1 FY25)

Segment-wise Revenue (H1 FY26-27):

  • Laboratory business: ₹1,044.53 million
  • Aligners business: ₹496.66 million
  • Other business: ₹21.23 million

Consolidated Assets and Liabilities (as at September 30, 2026):

  • Total assets: ₹3,163.89 million (₹2,939.72 million as at March 31, 2026)
  • Total equity: ₹2,657.16 million (₹2,441.12 million as at March 31, 2026)
  • Current assets: ₹1,993.88 million (₹1,887.22 million as at March 31, 2026)
  • Non-current assets: ₹1,170.01 million (₹1,052.50 million as at March 31, 2026)

Key Quantitative Figures - Standalone Results

Quarterly Performance (Q2 FY26-27 vs Q2 FY25-26):

  • Revenue from operations: ₹581.87 million (₹542.57 million in Q2 FY25)
  • Total income: ₹596.83 million (₹566.26 million in Q2 FY25)
  • Profit before tax: ₹59.99 million (₹72.75 million in Q2 FY25)
  • Profit after tax: ₹46.74 million (₹65.70 million in Q2 FY25)
  • Basic EPS: ₹0.85 (₹1.20 in Q2 FY25)

Half-Yearly Performance (H1 FY26-27 vs H1 FY25-26):

  • Revenue from operations: ₹1,133.87 million (₹1,043.70 million in H1 FY25)
  • Total income: ₹1,165.96 million (₹1,084.00 million in H1 FY25)
  • Profit before tax: ₹130.54 million (₹162.71 million in H1 FY25)
  • Profit after tax: ₹108.45 million (₹144.29 million in H1 FY25)
  • Basic EPS: ₹1.97 (₹2.63 in H1 FY25)

Standalone Assets and Liabilities (as at September 30, 2026):

  • Total assets: ₹2,976.28 million (₹2,887.56 million as at March 31, 2026)
  • Total equity: ₹2,588.09 million (₹2,470.50 million as at March 31, 2026)
  • Current assets: ₹1,484.67 million (₹1,442.43 million as at March 31, 2026)
  • Non-current assets: ₹1,491.61 million (₹1,445.13 million as at March 31, 2026)

Subsidiaries and Joint Ventures Included in Consolidation

1. Bizdent Devices Private Limited - Wholly owned subsidiary

2. Signature Smile Dental Clinic Private Limited - Subsidiary (88.88%)

3. Rich Smile Design LLP - Subsidiary (66.00%)

4. Laxmi Dental Lab USA INC. - Wholly owned subsidiary (71.43% owned by Holding Company, 28.57% by Bizdent Devices)

5. Diverse Dental Lab INC. - Subsidiary of Laxmi Dental Lab USA INC. (85.00%)

6. Illusion Dental Lab USA INC. - Wholly owned Subsidiary of Laxmi Dental Lab USA INC.

7. KlDS-E-Dental LLP - Joint Venture (60.00%)

8. IDBG Al Dent Global Private Limited - Joint Venture (49.00%)

Auditor's Report Details

  • MSKA & Associates LLP conducted limited review of both consolidated and standalone results
  • Unmodified opinion issued for both sets of results
  • Five subsidiaries with total assets of ₹258.68 million were reviewed by other auditors
  • One jointly controlled entity with net loss of ₹1.37 million for H1 FY26-27 was not subject to auditor review

IPO Fund Utilization as on September 30, 2026

  • Total IPO proceeds: ₹1,281.70 million
  • Utilized amount: ₹814.10 million
  • Unutilized amount: ₹467.60 million (temporarily invested in fixed deposits with banks)

Revised Object-wise Utilization:

1. Repayment of borrowings: ₹229.84 million (fully utilized)

2. Investment in subsidiaries for borrowing repayment: ₹46.00 million (fully utilized)

3. Funding capital expenditure: ₹177.81 million (fully utilized)

4. Investments in subsidiary for capital expenditure: ₹26.27 million (fully utilized)

5. General corporate purposes: ₹320.75 million (fully utilized)

6. New object - Acquisition of land and construction: ₹268.96 million (unutilized)

7. New object - Purchase of movable assets: ₹212.07 million (₹13.43 million utilized, ₹198.64 million unutilized)

Other Material Information

  • Board meeting held on November 03, 2026 from 04:00 PM to 05:10 PM IST
  • Scheme of merger of Bizdent Devices Private Limited with Holding Company pending Regional Director approval
  • Rich Smile Design LLP business operations discontinued during FY25-26
  • Impact of New Labour Codes resulted in exceptional item of ₹57.79 million in FY25-26 consolidated results and ₹51.56 million in standalone results
  • Shareholders approved variation in IPO objects and extension of utilization timeline at 22nd AGM held on September 25, 2026

Financial Impact Assessment

All financial impacts are quantified in the disclosure. The results show improved consolidated performance with revenue growth of 9.4% and profit growth of 17.6% YoY in Q2, while standalone performance showed revenue growth but profit decline.